The treatment a cancer patient receives next year may first have been debated in a congress hall this year. That is the quiet power of ESMO: it turns new evidence into shared standards that oncologists everywhere can use.

Inside ESMO: How Oncology's Biggest Conversations Turn Into Better Care

If you are a clinician, researcher or medical affairs professional, you have probably sat in one of its sessions. Here is what ESMO actually is, how its work reaches patients, and why ESMO Asia 2026 in Singapore is worth your time.

What is ESMO? The society behind the ESMO conference

ESMO, the European Society for Medical Oncology, is the leading professional organisation for medical oncology. Founded in 1975 and based in Lugano, Switzerland, it represents more than 50,000 oncology professionals worldwide.

Despite the "European" in its name, its reach is global. Its work falls into a few big areas:

Congresses

The flagship ESMO Congress each year, the ESMO conference most oncologists know, plus regional and specialist meetings such as ESMO Asia in Singapore.

Clinical guidelines

Evidence-based recommendations on how to diagnose, treat and follow up different cancers.

Education

Training and resources for oncologists at every stage of their career.

Policy

Advocating for equal access to effective cancer care, wherever a patient lives.

How ESMO is changing lives for the better

Most patients will never hear the name ESMO. Yet its work shapes the decisions made in their consultation rooms. Here is how.

1. New evidence reaches clinics faster

Practice-changing trial results are often presented first at an ESMO conference. Thousands of oncologists hear them at the same moment, discuss them in the hallway, and take them back to their own patients.

2. Shared standards of care

ESMO's clinical practice guidelines translate a flood of studies into clear recommendations. A patient in Singapore, Mumbai or Madrid is more likely to be offered a treatment backed by the best available evidence.

3. An honest measure of benefit

In 2015, ESMO introduced the Magnitude of Clinical Benefit Scale (ESMO-MCBS). It grades how much meaningful benefit a cancer medicine actually delivers, cutting through hype about "breakthroughs".

The World Health Organization's expert committee uses the scale as a screening tool when choosing cancer medicines for its Essential Medicines List. That list guides which drugs countries prioritise, so this work affects access to treatment far beyond Europe.

4. Care that fits Asia

Through its Pan-Asian Guidelines Adaptation (PAGA), ESMO works with oncology societies across Asia to adapt its guidelines to the region's patients, drug access and health systems. A standard is only useful if it can be applied where the patient is.

“A standard is only useful if it can be applied where the patient is.”

ESMO Asia 2026 in Singapore: dates, venue and what to expect

ESMO Asia 2026 takes place from 4 to 6 December at the Suntec Singapore Convention & Exhibition Centre. It brings together oncology professionals from across the Asia-Pacific region and beyond.

The programme focuses on the cancers most common in Asia, with sessions on biomarker-driven and targeted therapies, molecular oncology, rare cancers, artificial intelligence and access to treatment across diverse health systems. The Pan-Asian guideline sessions are a central feature.

For anyone treating patients in the region, ESMO Singapore is three days of the most relevant evidence, all in one place.

The part no one talks about: what happens after the congress

A congress only changes lives if what you learn there makes it home with you. Three days of sessions means hundreds of photos of slides, posters, badges and notes. A week later, most of it is buried in a phone gallery, and the one slide you need for Monday's tumour board is hard to find.

That is the problem we are building Gnaanam to solve. Capture slides, posters, QR codes and badges as you go, and Gnaanam files each one by conference, day, session and speaker. When you need it, you find it in seconds.

Capture. Slides, posters, QR codes and speaker badges as you go without missing a beat in crowded session halls.

Organise. Automatically filed by conference, day, track, session, and speaker with smart OCR.

Find. Search slide text, trial protocols, and investigator insights in seconds whenever you need them.

We Are Visiting in Person Suntec, Singapore

We're Attending ESMO Asia 2026 in Singapore. Let's Meet!

The Gnaanam team is visiting Singapore from 4 to 6 December 2026. We'd love to meet oncologists, researchers, and medical affairs teams to discuss congress workflows and share an early preview of Gnaanam.

When 4–6 December 2026
Where Suntec Singapore

Gnaanam is independent and not affiliated with ESMO.

FAQ

ESMO Asia 2026: Frequently Asked Questions

Quick answers about ESMO, the ESMO conference, and what to expect at ESMO Asia 2026 in Singapore.

What is ESMO?

ESMO is the European Society for Medical Oncology, a professional society representing more than 50,000 oncology professionals worldwide.

What is the ESMO conference?

The ESMO conference usually refers to the annual ESMO Congress. ESMO also runs regional meetings such as ESMO Asia.

When is ESMO Asia 2026?

ESMO Asia 2026 runs from 4 to 6 December 2026.

Where is ESMO Asia 2026 held?

At the Suntec Singapore Convention & Exhibition Centre, Singapore.

Who should attend ESMO Singapore?

Oncologists, researchers, fellows, nurses, pharmacists and medical affairs teams working in cancer care across the Asia-Pacific region.

ATTENDING MEDICAL CONFERENCES?

Capture Every Session, Never Lose a Slide

From ESMO to local symposia, Gnaanam keeps your clinical slides, trial posters, badges, and notes organized and searchable in seconds.